Hasil Pencarian (1)
small molecule | CAS: 656247-17-5
Nintedanib is a small molecule kinase inhibitor used in the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC).[L8453,L8459] It was first approved for use in the United States in 20…
Kategori:
Antifibrotic AgentsAntineoplastic AgentsAntineoplastic and Immunomodulating Agents
+14
Target Protein:
Vascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 2Vascular endothelial growth factor receptor 3
+9
Waktu ParuhThe terminal elimin…
Vol. DistribusiNintedanib appears …
KlirensNintedanib is has a…
Genetik
-